Monocyte activation test (MAT): Insight into examining regulations and markets prospects
Supported by:
13 November 2024
3:00pm
Shares
- Like
- Digg
- Del
- Tumblr
- VKontakte
- Buffer
- Love This
- Odnoklassniki
- Meneame
- Blogger
- Amazon
- Yahoo Mail
- Gmail
- AOL
- Newsvine
- HackerNews
- Evernote
- MySpace
- Mail.ru
- Viadeo
- Line
- Comments
- Yummly
- SMS
- Viber
- Telegram
- Subscribe
- Skype
- Facebook Messenger
- Kakao
- LiveJournal
- Yammer
- Edgar
- Fintel
- Mix
- Instapaper
- Copy Link
Join this webinar to learn about the current regulations on the monocyte activation test (MAT) and the new type of MAT entering the markets.
Implementation of the monocyte activation test (MAT) is gaining increasing importance in Europe. Find out about the regulatory considerations in the MAT market, as well as product availability and how to determine the most suitable MAT approach for your needs. This webinar will explore answers to key questions, including:
- Why does MAT have such a high relevance in Europe? Who is affected?
- What is the current development in worldwide pharmacopoeias regarding MAT?
- How should MAT be performed according to Ph. Eur.?
The session will also highlight the alternative MAT assay to the ELISA-based MAT, which has risen in popularity. Benefits of this alternative, such as addressing current customer needs on the market (e.g. less lot-to-lot- variation, stable supply chain and shorter assay time) will also be part of the discussion.
Key learning points:
- Understand the relevance of MAT implementation in EU
- Learn about the current status of the MAT in the different pharmacopoeia (USP, EP, JP, ChP)
- Find out how to perform a MAT assay, based on current guidelines
- Discover what the new MAT assay can offer, such as improving time management and more.
Interested? Register your details to sign up >>>
OUR SPEAKER
Vivien Knospe – Associate Sales Manager – Pyrogen & Endotoxin Specialist at FUJIFILM WAKO Chemicals Europe GmbH
Vivien has held the role of Associate Sales Manager – Endotoxin and Pyrogen Specialist since August 2023. She is a TÜV-certified Quality representative (ISO 9001) and GMP Manager (June and July 2023). Her experience also includes studying antimicrobial peptides – lantibiotics as a Research Assistant/PhD student at Heinrich-Heine-University of Duesseldorf. Vivien received a Master’s degree in Biochemistry from the Heinrich-Heine-University of Duesseldorf and a Bachelor degree in Biochemistry from the Ruprecht-Karls-University of Heidelberg.
FAQs
FAQs
Is the webinar free?
Yes – there is no charge to watch the webinar, either live or on-demand.
When will the webinar take place?
13 November 2024 at 3.00pm GMT.
Can I watch it later?
The webinar will become available to watch on-demand shortly after the live webinar takes place.
What are the benefits of attending live?
You’ll be able to ask the speakers your questions, which will be answered live in the Q&A towards the end of the session.
How long will the webinar be?
This webinar will last up to an hour.
What do I need to watch this webinar?
All you need is a computer with an internet connection. We recommend using headphones if possible if you’re in an office environment.
